Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing
PLOS One · 2025
DOI: 10.1371/journal.pone.0327714 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Zuzana Holesova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Geneton Ltd, Bratislava, Slovakia. Hauptthemen laut MEDLINE: Telomere, Fetus, Prenatal Diagnosis, Noninvasive Prenatal Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU, Recovery plan for Europe.
Abstract (Originalsprache)
Non-invasive prenatal testing (NIPT) has revolutionized prenatal diagnostics by providing a safer alternative to invasive techniques such as amniocentesis and chorionic villus sampling. NIPT detects chromosomal abnormalities through the analysis of cell-free fetal DNA (cffDNA) in maternal plasma. One of the critical factors influencing accuracy of NIPT is the fetal fraction (FF) – the proportion of fetal cell-free DNA relative to total cell-free DNA in maternal plasma. This study investigates the potential of using telomere length measurements as a novel biomarker for fetal fraction prediction in NIPT. Telomere-derived fragments, which differ between maternal and fetal DNA, may serve as a measure of FF due to the distinct telomere length. Specifically, deviations from the expected shorter telomere lengths of maternal DNA toward longer lengths could be more pronounced at higher FF levels. Various models incorporating telomere content and features selected by Ordinary Least Squares (OLS) were evaluated to enhance fetal fraction prediction. Our results showed that telomere content also works as an independent predictor (with Pearson correlation 0.23), yielding a small improvement in prediction precision when combined with traditional models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Geneton Ltd, Bratislava, Slovakia.
- Comenius University Science Park, Bratislava, Slovakia.
- Slovak Centre of Scientific and Technical Information, Bratislava, Slovakia.
- Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
- TRISOMYtest Ltd, Nitra, Slovakia.
- Medirex Group Academy, Nitra, Slovakia.
ORCID-Profile: Zuzana Holesova, Marcel Kucharik
Förderung
- NextGenerationEU, Recovery plan for Europe
Zitieren
APA
Holesova, Z., Budis, J., Kucharik, M., Gazdarica, J., Carska, D., Minarik, G., Hyblova, M., & Szemes, T. (2025). Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing. PLOS One. https://doi.org/10.1371/journal.pone.0327714
Vancouver
Holesova Z, Budis J, Kucharik M, Gazdarica J, Carska D, Minarik G, et al. Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing. PLOS One. 2025. doi:10.1371/journal.pone.0327714
BibTeX
@article{Holesova2025,
author = {Holesova, Zuzana and Budis, Jaroslav and Kucharik, Marcel and Gazdarica, Juraj and Carska, Daria and Minarik, Gabriel and Hyblova, Michaela and Szemes, Tomas},
title = {Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0327714}
}
EUVIMED